Jeena Sikho Lifecare (NSE:JSLL) Strong Profits May Be Masking Some Underlying Issues

The market shrugged off Jeena Sikho Lifecare Limited's (NSE:JSLL) solid earnings report. We think that investors might be worried about some concerning underlying factors.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

A Closer Look At Jeena Sikho Lifecare's Earnings

Many investors haven't heard of the accrual ratio from cashflow, but it is actually a useful measure of how well a company's profit is backed up by free cash flow (FCF) during a given period. To get the accrual ratio we first subtract FCF from profit for a period, and then divide that number by the average operating assets for the period. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.

As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future".

Jeena Sikho Lifecare has an accrual ratio of 0.70 for the year to March 2025. Statistically speaking, that's a real negative for future earnings. To wit, the company did not generate one whit of free cashflow in that time. In the last twelve months it actually had negative free cash flow, with an outflow of ₹432m despite its profit of ₹907.3m, mentioned above. We saw that FCF was ₹212m a year ago though, so Jeena Sikho Lifecare has at least been able to generate positive FCF in the past.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Jeena Sikho Lifecare.

Our Take On Jeena Sikho Lifecare's Profit Performance

As we have made quite clear, we're a bit worried that Jeena Sikho Lifecare didn't back up the last year's profit with free cashflow. For this reason, we think that Jeena Sikho Lifecare's statutory profits may be a bad guide to its underlying earnings power, and might give investors an overly positive impression of the company. But the good news is that its EPS growth over the last three years has been very impressive. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about Jeena Sikho Lifecare as a business, it's important to be aware of any risks it's facing. For instance, we've identified 2 warning signs for Jeena Sikho Lifecare (1 is concerning) you should be familiar with.

This note has only looked at a single factor that sheds light on the nature of Jeena Sikho Lifecare's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.